1091 – Laparoscopic sleeve gastrectomy following early breast cancer treatment: a retrospective case series

Authors

  • Jakeline Ferreira de Sousa Sampaio Borba
  • Geórgia Ferreira de Carvalho Linhares
  • Fernanda Caroline Leite Dias Moraes
  • Breno Dias Lima Ribeiro
  • Pedro José Aroucha Bringel Carvalho
  • Romerito Neiva Fonseca
  • Ozimo Pereira Gama Filho

DOI:

https://doi.org/10.29289/259453942025V36S11091

Keywords:

bariatric surgery, breast neoplasms, recurrence, weight loss, gastrectomy

Abstract

Introduction: High adiposity and obesity are associated with worse outcomes in breast cancer, including a higher risk of
recurrence, particularly in hormone-dependent disease. While bariatric surgery reduces weight and improves metabolic
markers—with evidence suggesting a reduction in overall cancer incidence and mortality—its role and feasibility after a
definitive breast cancer diagnosis and treatment remain uncertain.
Methods: This retrospective case series included ten women previously treated for stage I–II breast cancer who underwent laparoscopic sleeve gastrectomy 12 to 36 months after completing oncologic treatment. The primary outcomes
were recurrence (local, regional, or distant) and invasive disease-free survival, defined according to STEEP v2.0 criteria.
Perioperative complications were graded using the Clavien-Dindo classification.
Results: The mean age at cancer diagnosis was 49.3 years (standard deviation ±13.6 years), and the pre-bariatric body
mass index was 43.1±5.4 kg/m². The mean interval from oncologic treatment to surgery was 22.4±6.8 months. Thirty-day
complications occurred in 2/10 (20%) patients (all Clavien-Dindo I–II), with 0% mortality. Total weight loss at 12 and 24
months was 9.4±5.2% and 26.8±6.1%, respectively. Glycated hemoglobin decreased from 6.6±1.0% to 5.7±0.5% at 12 months,
and high-sensitivity C-reactive protein decreased from 6.8±3.1 mg/L to 3.0±1.5 mg/L. During a mean follow-up of 5.1±2.3
years post-bariatric surgery, one distant recurrence (in bone) was observed.
Conclusion: Laparoscopic sleeve gastrectomy following early breast cancer treatment is feasible, demonstrating low
morbidity and significant weight and metabolic improvements. The low recurrence rate serves as a hypothesis-generating finding, emphasizing the need for prospective studies using time-dependent exposure modeling to mitigate biases.
Ethics: Research Ethics Committee Approval (CAAE 83509724400005086).

Downloads

Download data is not yet available.

Downloads

Published

2026-10-19

How to Cite

Borba, J. F. de S. S., Linhares, G. F. de C., Moraes, F. C. L. D., Ribeiro, B. D. L., Carvalho, P. J. A. B., Fonseca, R. N., & Gama Filho, O. P. (2026). 1091 – Laparoscopic sleeve gastrectomy following early breast cancer treatment: a retrospective case series. Mastology, 36(suppl. 1). https://doi.org/10.29289/259453942025V36S11091

Issue

Section

Locoregional Treatment Section